These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
578 related items for PubMed ID: 16873437
1. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. Arch Dis Child; 2006 Oct; 91(10):814-9. PubMed ID: 16873437 [Abstract] [Full Text] [Related]
2. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. van Hoffen E, Ruiter B, Faber J, M'Rabet L, Knol EF, Stahl B, Arslanoglu S, Moro G, Boehm G, Garssen J. Allergy; 2009 Mar; 64(3):484-7. PubMed ID: 18507650 [Abstract] [Full Text] [Related]
3. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E. J Biol Regul Homeost Agents; 2012 Mar; 26(3 Suppl):49-59. PubMed ID: 23158515 [Abstract] [Full Text] [Related]
4. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Costalos C, Kapiki A, Apostolou M, Papathoma E. Early Hum Dev; 2008 Jan; 84(1):45-9. PubMed ID: 17433577 [Abstract] [Full Text] [Related]
5. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Kapiki A, Costalos C, Oikonomidou C, Triantafyllidou A, Loukatou E, Pertrohilou V. Early Hum Dev; 2007 May; 83(5):335-9. PubMed ID: 16978805 [Abstract] [Full Text] [Related]
6. Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. van der Aa LB, Heymans HS, van Aalderen WM, Sillevis Smitt JH, Knol J, Ben Amor K, Goossens DA, Sprikkelman AB, Synbad Study Group. Clin Exp Allergy; 2010 May; 40(5):795-804. PubMed ID: 20184604 [Abstract] [Full Text] [Related]
7. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Schouten B, Van Esch BC, Kormelink TG, Moro GE, Arslanoglu S, Boehm G, Knippels LM, Redegeld FA, Willemsen LE, Garssen J. Pediatr Allergy Immunol; 2011 Aug; 22(5):537-42. PubMed ID: 21771085 [Abstract] [Full Text] [Related]
8. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. Magne F, Hachelaf W, Suau A, Boudraa G, Bouziane-Nedjadi K, Rigottier-Gois L, Touhami M, Desjeux JF, Pochart P. J Pediatr Gastroenterol Nutr; 2008 May; 46(5):580-8. PubMed ID: 18493215 [Abstract] [Full Text] [Related]
9. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Pediatrics; 2008 Apr; 121(4):e850-6. PubMed ID: 18332075 [Abstract] [Full Text] [Related]
10. [Randomised placebo controlled double blind study on the effect of prebiotic oligosaccharides on intestinal flora in healthy infants]. Decsi T, Arató A, Balogh M, Dolinay T, Kanjo AH, Szabó E, Várkonyi A. Orv Hetil; 2005 Nov 27; 146(48):2445-50. PubMed ID: 16408384 [Abstract] [Full Text] [Related]
11. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Halken S. Pediatr Allergy Immunol; 2004 Jun 27; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698 [Abstract] [Full Text] [Related]
12. Clinical effects of kestose, a prebiotic oligosaccharide, on the treatment of atopic dermatitis in infants. Shibata R, Kimura M, Takahashi H, Mikami K, Aiba Y, Takeda H, Koga Y. Clin Exp Allergy; 2009 Sep 27; 39(9):1397-403. PubMed ID: 19508323 [Abstract] [Full Text] [Related]
13. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. Grüber C, van Stuijvenberg M, Mosca F, Moro G, Chirico G, Braegger CP, Riedler J, Boehm G, Wahn U, MIPS 1 Working Group. J Allergy Clin Immunol; 2010 Oct 27; 126(4):791-7. PubMed ID: 20832848 [Abstract] [Full Text] [Related]
14. Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics. Puccio G, Cajozzo C, Meli F, Rochat F, Grathwohl D, Steenhout P. Nutrition; 2007 Jan 27; 23(1):1-8. PubMed ID: 17189085 [Abstract] [Full Text] [Related]
15. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. Scholtens PA, Alles MS, Bindels JG, van der Linde EG, Tolboom JJ, Knol J. J Pediatr Gastroenterol Nutr; 2006 May 27; 42(5):553-9. PubMed ID: 16707980 [Abstract] [Full Text] [Related]
16. Effect of a whey-predominant starter formula containing LCPUFAs and oligosaccharides (FOS/GOS) on gastrointestinal comfort in infants. Vivatvakin B, Mahayosnond A, Theamboonlers A, Steenhout PG, Conus NJ. Asia Pac J Clin Nutr; 2010 May 27; 19(4):473-80. PubMed ID: 21147707 [Abstract] [Full Text] [Related]
17. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Haarman M, Knol J. Appl Environ Microbiol; 2006 Apr 27; 72(4):2359-65. PubMed ID: 16597930 [Abstract] [Full Text] [Related]
18. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, Lee SY, Ahn KM, Ji GE. Pediatr Allergy Immunol; 2010 Mar 27; 21(2 Pt 2):e386-93. PubMed ID: 19840300 [Abstract] [Full Text] [Related]
19. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. Taylor AL, Dunstan JA, Prescott SL. J Allergy Clin Immunol; 2007 Jan 27; 119(1):184-91. PubMed ID: 17208600 [Abstract] [Full Text] [Related]
20. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG. Br J Nutr; 2005 Nov 27; 94(5):783-90. PubMed ID: 16277782 [Abstract] [Full Text] [Related] Page: [Next] [New Search]